The IBMS has issued a response to Professor Dame Sally Davies’ annual report, which calls on the government to develop genomic medicine’s role in the NHS.
Sarah May, IBMS Deputy Chief Executive, commented on Dame Sally’s focus on genomic testing.
“We support the Chief Medical Officer’s view that DNA testing should become standard across cancer care,” she said.
“The UK has a workforce of highly skilled and trained biomedical scientists that are preparing to meet this new diagnostic and treatment challenge.”
She added that the IBMS is launching two new molecular pathology qualifications in 2017.
These are “intended to directly support the new and expanding science and technology and help to achieve Dame Sally’s vision for personalised diagnosis and healthcare”.
